ArticleFrontiers in immunology2025

Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer.

Hongwei Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.